Latin America

Depilatories in Chile saw a slight increase in current value terms in 2023. This was primarily driven by price rises, as sales continued to decline in volume terms. However, the category maintained current value sales significantly higher than those…

Depilatories saw modest current value growth in Colombia in 2023. Economic pressures compelled some consumers to cut back on non-essential spending during the year, including visits to beauty salons for hair removal services, such as waxing and laser…

Depilatories in Costa Rica showed a markedly improved performance in volume terms in 2023, with overall sales increasing at a double-digit rate following marginal growth in 2022. This was partly explained by the strong recovery in consumer confidence…

Depilatories in the Dominican Republic witnessed steady volume growth in 2023. Demographic groups with lower purchasing power have become more cautious with their purchases in recent years, with inflation taking its toll. Less essential products such…

Reckitt Benckiser’s Veet remained the dominant leading brand in hair removers/bleaches in 2023, despite the brand’s volume sales declining significantly over the course of the year after recording an exceptional sales performance earlier in the…

2023 saw depilatories rise in both volume and current value terms in 2023. During the pandemic and its lockdowns, local consumers spend more time at home and there was reduced need to remove body hair, undermining sales. Subsequently, and with the…

Although many employees started returning to the workplace in 2021, many organisations opted to maintain remote working formats for strategic reasons of cost savings and health protection. However, as infection rates declined and regulators relaxed…

The expansion of depilatories in 2023 was tempered by the growth in in-salon beauty treatments in Peru. Cosmetic hair removal treatments, such as laser treatments, are seeing a growing acceptance among Peruvian consumers, thus impacting the frequency…

2023 was the third year in a row that depilatories in Uruguay experienced volume sales decreases, with declining demand registered in all three of the categories that comprise depilatories: hair removers/bleaches, women’s pre-shave and women’s razors…

Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…

With society operating normally once again, after the pandemic, visits to doctors in relation to skin conditions have increased. This is seeing products such as topical antifungals, vaginal antifungals, cold sore treatments, and haemorrhoid…

Dermatologicals is set to maintain a healthy growth trajectory in current value terms in Brazil in 2023, in line with the increase recorded in 2022, driven mainly by price rises. The pandemic years were marked by a reduction in Brazilians’ purchasing…

Dermatologicals maintain a healthy growth trajectory in line with figures recorded in 2022, retaining significant value sales that surpass pre-pandemic levels. While this category typically demonstrates notable stability and does not exhibit…

Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations…

As consumers face stress due to economic uncertainty and skin imbalances after COVID-19, many suffer from hair loss, helping category growth. While some consumers opt for dietary supplements to avoid hair loss, others turn to shampoos or other…

Despite the challenging economic conditions affecting the country, consumers continue to purchase a variety of dermatological products as awareness about treating certain conditions increases. Categories such as haemorrhoid treatments, medicated…

Medicated shampoo is expected to register the highest current value growth in dermatologicals in 2023, with the big winner being Genommalab’s Medicasp. This brand has significantly increased value share over the review period. With substantial…

Top topical antifungals brands such as Canesten (Bayer), Lamisil (Haleon), and Unesia (Genomma) keep this segment competitive as each continues vying for more market share. Consumer demand for these products is expected to remain strong over the…

While sales of dermatologicals continue to grow in 2023, reflecting a recovery from pandemic-related disruptions. demand is stabilising. Mexicans are no longer facing increased risks to their skin compared to the previous year, and some…

Dermatologicals, in some regards, are driven by environmental factors. As such, the emergence of the El Niño Costero climatological event, which increased temperatures in Peru, especially along the coast, ultimately resulted in a higher number of…